Skip to content

Whittier Daily News

64°F
Monday, November 24th 2025

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)

9.115 +0.205 (+2.30%)
Streaming Delayed Price Updated: 3:42 PM EST, Nov 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 68,055
Open 8.920
Bid (Size) 9.100 (100)
Ask (Size) 9.130 (100)
Prev. Close 8.910
Today's Range 8.920 - 9.130
52wk Range 8.760 - 30.36
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lost Money on Telix Pharmaceuticals Ltd. (TLX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy Fraud Lawsuit
News headline image
Lost Money on Telix Pharmaceuticals Ltd. (TLX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Economy Fraud Lawsuit

Performance

YTD
-39.2%
-39.2%
1 Month
-15.8%
-15.8%
3 Month
-25.3%
-25.3%
6 Month
-45.9%
-45.9%
1 Year
-39.8%
-39.8%

More News

Read More
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Shareholders That Lost Money on Telix Pharmaceuticals Ltd. (TLX) Should Contact Levi & Korsinsky About Pending Class Action - TLX
Via TheNewswire.com
Topics Economy Fraud Lawsuit
News headline image
Shareholders That Lost Money on Telix Pharmaceuticals Ltd. (TLX) Should Contact Levi & Korsinsky About Pending Class Action - TLX
Via NewMediaWire
Topics Economy Fraud Lawsuit
News headline image
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors of Telix, Freeport, and Primo Brands to Contact the Firm About their Rights Before Lead Plaintiff Deadlines
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
TLX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Investors Who Lost Money on Telix Pharmaceuticals Ltd. (TLX) Should Contact Levi & Korsinsky About Pending Class Action - TLX
Via NewMediaWire
Topics Economy Fraud Lawsuit
News headline image
Investors Who Lost Money on Telix Pharmaceuticals Ltd. (TLX) Should Contact Levi & Korsinsky About Pending Class Action - TLX
Via TheNewswire.com
Topics Economy Fraud Lawsuit
News headline image
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Shareholders of Telix Pharmaceuticals Ltd. Should Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX
Via NewMediaWire
Topics Economy Fraud Lawsuit
News headline image
Shareholders of Telix Pharmaceuticals Ltd. Should Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX
Via TheNewswire.com
Topics Economy Fraud Lawsuit
News headline image
TLX LAWSUIT ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline
Via NewMediaWire
Topics Economy Fraud Lawsuit
News headline image
TLX LAWSUIT ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline
Via TheNewswire.com
Topics Economy Fraud Lawsuit
News headline image
Investor Notice: Robbins LLP Informs Investors of the Telix Pharmaceuticals Ltd. Securities Class Action
From Robbins LLP
Via GlobeNewswire
News headline image
Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Deadline Approaching: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Law Offices of Frank R. Cruz Encourages Telix Pharmaceuticals Limited (TLX) Shareholders to Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Telix Pharmaceuticals Limited (TLX) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter -- Hagens Berman
From Hagens Berman
Via Business Wire

Frequently Asked Questions

Is Telix Pharmaceuticals Limited - American Depositary Shares publicly traded?
Yes, Telix Pharmaceuticals Limited - American Depositary Shares is publicly traded.
What exchange does Telix Pharmaceuticals Limited - American Depositary Shares trade on?
Telix Pharmaceuticals Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares?
The ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares is TLX on the Nasdaq Stock Market
What is the current price of Telix Pharmaceuticals Limited - American Depositary Shares?
The current price of Telix Pharmaceuticals Limited - American Depositary Shares is 9.115
When was Telix Pharmaceuticals Limited - American Depositary Shares last traded?
The last trade of Telix Pharmaceuticals Limited - American Depositary Shares was at 11/24/25 03:42 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.